题名

醫療給付改善方案與照護過程對糖尿病病人健康結果之影響

并列篇名

The Effects of Pay-for-Performance and Process of Care on Health Outcomes of Diabetic Patients

DOI

10.6342/NTU.2013.01947

作者

譚家惠

关键词

糖尿病 ; 論質計酬 ; 併發症 ; 心血管疾病 ; 傾向分數法 ; diabetes ; pay-for-performance ; complication ; cardiovascular disease ; propensity score method

期刊名称

國立臺灣大學健康政策與管理研究所學位論文

卷期/出版年月

2013年

学位类别

博士

导师

楊銘欽

内容语文

繁體中文

中文摘要

背景:目前已有許多文獻探討論質計酬方案對於照護品質的影響,然而論質計酬方案對於照護結果的影響,卻少有著墨。 目的:本研究目的為探討第二型糖尿病病人是否參加論質計酬方案對於其糖尿病相關併發症發生情形之影響。 材料與方法:本研究為固定世代長期追蹤研究,平均追蹤期間為五年,資料來源為國家衛生研究院提供之2005年承保抽樣歸人檔,以2004-2006年新診斷的糖尿病病人世代(以門診出現三次以上糖尿病診斷(ICD-9-CM: 250.xx)或住院主診斷出現一次糖尿病診斷,並排除前一年門、住診記錄有糖尿病診斷者)為研究對象。研究組定義為於追蹤期間(2004-2010年)加入論質計酬方案,且至少接受完整照護一年以上者,而對照組為追蹤期間內,從未加入該方案者;由於病人是否加入論質計酬並非隨機分派(randomization)的情形,為了增加兩組間的可比較性,因此採用傾向分數配對法(propensity score matching),分析六大類糖尿病相關併發症(包括眼睛病變、神經病變、腎臟病變、腦血管病變、心血管疾病與周邊血管病變等)之發生情形,並透過不同傾向分數法與存活分析,估計糖尿病病人是否參加論質計酬方案對於糖尿病人心血管併發症發生的影響;整體資料以SAS 9.3版套裝軟體進行資料處理與統計分析。 結果:新診斷且無併發症的糖尿病人,參與論質計酬方案超過12月可降低其發生心血管併發症的危險,依據不同傾向分數法估計之風險值為0.60至0.62之間;此外,參與論質計酬方案可顯著降低糖尿病人發生心臟衰竭、心肌梗塞與中風的風險(HR=0.53-0.65)。在不同的傾向分數法中,使用傾向分數配對與傾向分數加權法,可大幅降低兩組樣本間的系統性誤差。 結論:新診斷且無併發症的糖尿病人參加論質計酬方案,可有效降低其發生心血管併發症的危險;此外,當估計介入的相對風險時,使用傾向分數配對與傾向分數加權法,可有效降低兩組樣本間的系統性誤差。

英文摘要

Objective: A number of studies have examined the impacts of pay-for-performance programs on quality of care, but little is known about long-term effects of these programs on the health care outcomes. Objective: The study aimed to examine the effects of the pay-for-performance program for type 2 diabetes patients on diabetes-related complications. Materials and methods: A longitudinal cohort study with 5-year follow-up was used to evaluate the impact of pay-for-performance program on diabetes-related complications. Research materials came from claims files of the Longitudinal Health Insurance Database (LHID) 2005 released from the Nation Health Research Institute. Patients newly diagnosed as diabetes (with more than 3 times of ambulatory visits diagnosed as diabetes [ICD-9-CM: 250.xx] or 1 time hospitalization with major diagnosis of diabetes) in 2004-2006 were included in the study. The case group were defined as joined the pay-for-performance program and received the comprehensive care over 12 months during 2004 to 2010. The control group were defined as never joined the pay-for-performance program during follow-up period. Patients who involved the pay-for-performance program or not is not randomization, we applied the propensity score matching (PSM) as a mean to increase the comparatives between these two groups. The incidences of six diabetes-related complications, including retinopathy, neuropathy, nephropathy, cerebrovascular, cardiovascular, peripheral vascular disease and metabolic disease) were analysed. Different propensity score methods and survival analysis were use to estimate whether involved in the pay-for-performance program was able to decrease the risk of cardiovascular events for diabetes patients. The SAS v9.3 package software was used the database process and statistical analyses. Results: Patients with newly diagnosed diabetes who participated in the pay-for-performance program for over 12 months experienced cardiovascular event significantly later than non-participants. The marginal hazard ratios of different propensity score method ranged from 0.60 to 0.63. There were significantly different risk of heart failure, myocardial infarction and stroke between those participated in the pay-for-performance program for over 12 months and those did not. Of these propensity score methods, propensity score matching and inverse probability of treatment weighting (IPTW) using propensity score resulted in the estimate with lower standardized difference of means between participant and non-participant groups. Conclusions: Cardiovascular events were significantly reduced over 5-year period among patients newly diagnosed with diabetes who participated in the pay-for-performance program for over 12 months. When estimating relative effects of interventions, propensity score matching and IPTW using the propensity score were recommended to apply to reduce the systematic bias between groups.

主题分类 醫藥衛生 > 預防保健與衛生學
公共衛生學院 > 健康政策與管理研究所
社會科學 > 社會科學綜合
参考文献
  1. Adler, A. I., R. J. Stevens, S. E. Manley, R. W. Bilous, C. A. Cull, R. R. Holman and U. Group (2003). "Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)." Kidney International 63(1): 225-232.
    連結:
  2. American Diabetes Association (2010). "Standards of Medical Care in Diabetes-2010." Diabetes Care 33: S11-S61.
    連結:
  3. Arday, D. R., B. B. Fleming, D. K. Keller, P. W. Pendergrass, R. J. Vaughn, J. M. Turpin and D. A. Nicewander (2002). "Variation in diabetes care among states - Do patient characteristics matter?" Diabetes Care 25(12): 2230-2237.
    連結:
  4. Austin, P. C. (2009). "Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples." Statistics in Medicine 28(25): 3083-3107.
    連結:
  5. Austin, P. C. (2009). "The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies." Medical Decision Making 29(6): 661-677.
    連結:
  6. Austin, P. C. (2009). "Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research." Communications in Statistics-Simulation and Computation 38(6): 1228-1234.
    連結:
  7. Austin, P. C. (2010). "Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model." Journal of Clinical Epidemiology 63(1): 2-6.
    連結:
  8. Austin, P. C. (2011). "Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples." Statistics in Medicine 30(11): 1292-1301.
    連結:
  9. Austin, P. C. (2011). "An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies." Multivariate Behavioral Research 46(3): 399-424.
    連結:
  10. Austin, P. C. (2011). "Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies." Pharm Stat 10(2): 150-161.
    連結:
  11. Austin, P. C. (2011). "A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality." Multivariate Behav Res 46(1): 119-151.
    連結:
  12. Austin, P. C., P. Grootendorst and G. M. Anderson (2007). "A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study." Statistics in Medicine 26(4): 734-753.
    連結:
  13. Austin, P. C., P. Grootendorst, S. L. T. Normand and G. M. Anderson (2007). "Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: A Monte Carlo study (p n/a)." Statistics in Medicine 26(16): 3208-3210.
    連結:
  14. Berk, R. A. (2004). Regression analysis : a constructive critique. Thousand Oaks, Calif., Sage Publications.
    連結:
  15. Bjork, S. (2001). "The cost of diabetes and diabetes care." Diabetes Research and Clinical Practice 54: S13-S18.
    連結:
  16. Campbell, S. M., D. Reeves, E. Kontopantelis, B. Sibbald and M. Roland (2009). "Effects of Pay for Performance on the Quality of Primary Care in England." New England Journal of Medicine 361(4): 368-378.
    連結:
  17. Cepeda, M. S., R. Boston, J. T. Farrar and B. L. Strom (2003). "Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders." American Journal of Epidemiology 158(3): 280-287.
    連結:
  18. Chang, C. J., F. H. Lu, Y. C. Yang, J. S. Wu, T. J. Wu, M. S. Chen, L. M. Chuang and T. Y. Tai (2000). "Epidemiologic study of type 2 diabetes in Taiwan." Diabetes Research and Clinical Practice 50: S49-S59.
    連結:
  19. Chang, R. E., S. P. Lin and D. C. Aron (2012). "A Pay-For-Performance Program In Taiwan Improved Care For Some Diabetes Patients, But Doctors May Have Excluded Sicker Ones." Health Affairs 31(1): 93-102.
    連結:
  20. Chen, H. F., C. A. Ho and C. Y. Li (2006). "Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures - Evidence from a cohort of a half-million diabetic patients." Diabetes Care 29(11): 2409-2414.
    連結:
  21. Chen, P. C., Y. C. Lee and R. N. Kuo (2012). "Differences in patient reports on the quality of care in a diabetes pay-for-performance program between 1 year enrolled and newly enrolled patients." International Journal for Quality in Health Care 24(2): 189-196.
    連結:
  22. Chen, T. T., K. P. Chung, I. C. Lin and M. S. Lai (2011). "The Unintended Consequence of Diabetes Mellitus Pay-for-Performance (P4P) Program in Taiwan: Are Patients with More Comorbidities or More Severe Conditions Likely to Be Excluded from the P4P Program?" Health Services Research 46(1): 47-60.
    連結:
  23. Cheng, C. L., Y. H. Kao, S. J. Lin, C. H. Lee and M. L. Lai (2011). "Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan." Pharmacoepidemiol Drug Saf 20(3): 236-242.
    連結:
  24. Cheng, S. H., T. T. Lee and C. C. Chen (2012). "A Longitudinal Examination of a Pay-for-Performance Program for Diabetes Care Evidence From a Natural Experiment." Medical Care 50(2): 109-116.
    連結:
  25. Chou, P., C. L. Li and S. T. Tsai (2001). "Epidemiology of type 2 diabetes in Taiwan." Diabetes Research and Clinical Practice 54: S29-S35.
    連結:
  26. Chuang, S. Y., P. F. Hsu, S. H. Sung, P. Chou and C. H. Chen (2010). "Diabetes and 15-year Cardiovascular Mortality in a Chinese Population: Differential Impact of Hypertension and Metabolic Syndrome." Journal of the Chinese Medical Association 73(5): 234-240.
    連結:
  27. D'Agostino, R. B., Jr. (1998). "Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group." Stat Med 17(19): 2265-2281.
    連結:
  28. De Berardis, G., F. Pellegrini, M. Franciosi, M. Belfiglio, B. Di Nardo, S. Greenfield, S. H. Kaplan, M. C. Rossi, M. Sacco, G. Tognoni, M. Valentini, A. Nicolucci and E. D. S. G. Qu (2008). "Quality of diabetes care predicts the development of cardiovascular events: results of the QuED study." Nutr Metab Cardiovasc Dis 18(1): 57-65.
    連結:
  29. De Berardis, G., F. Pellegrini, M. Franciosi, M. Belfiglio, M. Sacco, M. Valentini, A. Nicolucci and Q. S. Grp (2002). "Quality of care and outcomes in Type 2 diabetic patients: a comparison between general practice and diabetes clinics." Diabetologia 45: A308-A308.
    連結:
  30. Dunstan, D. W., P. Z. Zimmet, T. A. Welborn, M. P. De Courten, A. J. Cameron, R. A. Sicree, T. Dwyer, S. Colagiuri, D. Jolley, M. Knuiman, R. Atkins and J. E. Shaw (2002). "The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study." Diabetes Care 25(5): 829-834.
    連結:
  31. Eijkenaar, F. (2012). "Pay for Performance in Health Care: An International Overview of Initiativess." Medical Care Research and Review 69(3): 251-276.
    連結:
  32. Ettner, S. L., T. J. Thompson, M. R. Stevens, C. M. Mangione, C. Kim, W. N. Steers, J. Goewey, A. F. Brown, R. S. Chung, K. M. V. Narayan and T. S. Grp (2006). "Are physician reimbursement strategies associated with processes of care and patient satisfaction for patients with diabetes in managed care?" Health Services Research 41(4): 1221-1241.
    連結:
  33. Fagan, P. J., A. B. Schuster, C. Boyd, J. A. Marsteller, M. Griswold, S. M. E. Murphy, L. Dunbar and C. B. Forrest (2010). "Chronic Care Improvement in Primary Care: Evaluation of an Integrated Pay-for-Performance and Practice-Based Care Coordination Program among Elderly Patients with Diabetes." Health Services Research 45(6): 1763-1782.
    連結:
  34. Fleming, B. B., S. Greenfield, M. M. Engelgau, L. M. Pogach, S. B. Clauser, M. A. Parrott and D. Grp (2001). "The Diabetes Quality Improvement Project - Moving science into health policy to gain an edge on the diabetes epidemic." Diabetes Care 24(10): 1815-1820.
    連結:
  35. Gadsby, R. (2002). "Epidemiology of diabetes." Advanced Drug Delivery Reviews 54(9): 1165-1172.
    連結:
  36. Glickman, S. W., F. S. Ou, E. R. DeLong, M. T. Roe, B. L. Lytle, J. Mulgund, J. S. Rumsfeld, W. B. Gibler, E. M. Ohman, K. A. Schulman and E. D. Peterson (2007). "Pay for performance, quality of care, and outcomes in acute myocardial infarction." Jama-Journal of the American Medical Association 297(21): 2373-2380.
    連結:
  37. Greenland, S. (2000). "Causal analysis in the health sciences." Journal of the American Statistical Association 95(449): 286-289.
    連結:
  38. Gulliford, M. C., H. Dodhia, S. Sivaprasad and M. Ashworth (2010). "Family Practices' Achievement of Diabetes Quality of Care Targets and Risk of Screen-Detected Diabetic Retinopathy." Plos One 5(4).
    連結:
  39. Guo, S. and M. W. Fraser (2010). Propensity score analysis : statistical methods and applications. Thousand Oaks, Calif., Sage Publications.
    連結:
  40. Guttmann, A., M. Nakhla, M. Henderson, T. To, D. Daneman, K. Cauch-Dudek, X. Wang, K. Lam and J. Hux (2010). "Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children." Pediatric Diabetes 11(2): 122-128.
    連結:
  41. Hale, N. L., K. J. Bennett and J. C. Probst (2010). "Diabetes care and outcomes: disparities across rural America." J Community Health 35(4): 365-374.
    連結:
  42. Harris, M. I., K. M. Flegal, C. C. Cowie, M. S. Eberhardt, D. E. Goldstein, R. R. Little, H. M. Wiedmeyer and D. D. Byrd-Holt (1998). "Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults - The Third National Health and Nutrition Examination Survey, 1988-1994." Diabetes Care 21(4): 518-524.
    連結:
  43. Haviland, A., D. S. Nagin and P. R. Rosenbaum (2007). "Combining propensity score matching and group-based trajectory analysis in an observational study." Psychol Methods 12(3): 247-267.
    連結:
  44. Hickman, M., N. Drummond and J. Grimshaw (1994). "A Taxonomy of Shared Care for Chronic Disease." Journal of Public Health Medicine 16(4): 447-454.
    連結:
  45. Hillman, A. L., K. Ripley, N. Goldfarb, I. Nuamah, J. Weiner and E. Lusk (1998). "Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care." Am J Public Health 88(11): 1699-1701.
    連結:
  46. Ho, D. E., K. Imai, G. King and E. A. Stuart (2007). "Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference." Political Analysis 15(3): 199-236.
    連結:
  47. Ho, J. D., C. C. Hu and H. C. Lin (2009). "Open-angle glaucoma and the risk of stroke development: a 5-year population-based follow-up study." Stroke 40(8): 2685-2690.
    連結:
  48. Holman, R. R., S. K. Paul, M. A. Bethel, D. R. Matthews and H. A. W. Neil (2008). "10-year follow-up of intensive glucose control in type 2 diabetes." New England Journal of Medicine 359(15): 1577-1589.
    連結:
  49. Imbens, G. W. (2004). "Nonparametric estimation of average treatment effects under exogeneity: A review." Review of Economics and Statistics 86(1): 4-29.
    連結:
  50. Institute of Medicine (U.S.). Committee on Quality of Health Care in America. (2001). Crossing the quality chasm : a new health system for the 21st century. Washington, D.C., National Academy Press.
    連結:
  51. Kalyani, R. R., C. D. Saudek, F. L. Brancati and E. Selvin (2010). "Association of Diabetes, Comorbidities, and A1C With Functional Disability in Older Adults Results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006." Diabetes Care 33(5): 1055-1060.
    連結:
  52. Khunti, K., R. Gadsby, C. Millett, A. Majeed and M. Davies (2007). "Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes." Diabetic Medicine 24(12): 1436-1441.
    連結:
  53. King, H., R. E. Aubert and W. H. Herman (1998). "Global burden of diabetes, 1995-2025 - Prevalence, numerical estimates, and projections." Diabetes Care 21(9): 1414-1431.
    連結:
  54. Klein, J. P. and M. L. Moeschberger (1997). Survival Analysis: Techniques for Censored and Truncated Data. New York, Springer-Verlag.
    連結:
  55. Krop, J. S., C. D. Saudek, W. E. Weller, N. R. Powe, T. Shaffer and G. F. Anderson (1999). "Predicting expenditures for medicare beneficiaries with diabetes - A prospective cohort study from 1994 to 1996." Diabetes Care 22(10): 1660-1666.
    連結:
  56. Lai, C. L. and Y. H. Hou (2013). "The association of clinical guideline adherence and pay-for-performance among patients with diabetes." Journal of the Chinese Medical Association 76(2): 102-107.
    連結:
  57. Li, C. L., H. Y. Chang and J. R. Lu (2009). "Health-related quality of life predicts hospital admission within 1 year in people with diabetes: a nationwide study from Taiwan." Diabetic Medicine 26(10): 1055-1062.
    連結:
  58. Lin, C. C., M. S. Lai, C. Y. Syu, S. C. Chang and F. Y. Teng (2005). "Accuracy of diabetes diagnosis in health insurance claims data in Taiwan." Journal of the Formosan Medical Association 104(3): 157-163.
    連結:
  59. Lin, D. Y. and L. J. Wei (1989). "The Robust Inference for the Cox Proportional Hazards Model." Journal of the American Statistical Association 84(408): 1074-1078.
    連結:
  60. Lin, T., P. Chou, M. S. Lai, S. T. Tsai and T. Y. Tai (2001). "Direct costs-of-illness of patients with diabetes mellitus in Taiwan." Diabetes Research and Clinical Practice 54: S43-S46.
    連結:
  61. Lin, T., P. S. Chou, S. T. Tsai, Y. C. Lee and T. Y. Tai (2004). "Predicting factors associated with costs of diabetic patients in Taiwan." Diabetes Research and Clinical Practice 63(2): 119-125.
    連結:
  62. Lippi Bruni, M., L. Nobilio and C. Ugolini (2009). "Economic incentives in general practice: The impact of pay-for-participation and pay-for-compliance programs on diabetes care." Health Policy 90(2-3): 140-148.
    連結:
  63. Little, R. J. and D. B. Rubin (2000). "Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches." Annu Rev Public Health 21: 121-145.
    連結:
  64. Liu, Z. L., C. W. Fu, W. B. Wang and B. A. Xu (2010). "Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China." Health and Quality of Life Outcomes 8: -.
    連結:
  65. Lunceford, J. K. and M. Davidian (2004). "Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study." Statistics in Medicine 23(19): 2937-2960.
    連結:
  66. Martens, E. P., W. R. Pestman, A. de Boer, S. V. Belitser and O. H. Klungel (2008). "Systematic differences in treatment effect estimates between propensity score methods and logistic regression." International Journal of Epidemiology 37(5): 1142-1147.
    連結:
  67. Mattout, C., D. Bourgeois and P. Bouchard (2006). "Type 2 diabetes and periodontal indicators: epidemiology in France 2002-2003." Journal of Periodontal Research 41(4): 253-258.
    連結:
  68. McClellan, W. M., L. Millman, R. Presley, J. Couzins and W. D. Flanders (2003). "Improved diabetes care by primary care physicians: results of a group-randomized evaluation of the Medicare Health Care Quality Improvement Program (HCQIP)." J Clin Epidemiol 56(12): 1210-1217.
    連結:
  69. McNeely, M. J. and E. J. Boyko (2005). "Diabetes-related comorbidities in Asian Americans - Results of a National Health Survey." Journal of Diabetes and Its Complications 19(2): 101-106.
    連結:
  70. Miller, C. K., J. L. Kristeller, A. Headings, H. Nagaraja and W. F. Miser (2012). "Comparative Effectiveness of a Mindful Eating Intervention to a Diabetes Self-Management Intervention among Adults with Type 2 Diabetes: A Pilot Study." Journal of the Academy of Nutrition and Dietetics 112(11): 1835-1842.
    連結:
  71. Mohan, V., M. Deepa, R. Deepa, C. S. Shanthirani, S. Farooq, A. Ganesan and M. Datta (2006). "Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India—the Chennai Urban Rural Epidemiology Study (CURES-17)." Diabetologia 49(6): 1175-1178.
    連結:
  72. Morgan, C. L., C. J. Currie, N. C. H. Stott, M. Smithers, C. C. Butler and J. R. Peters (2000). "The prevalence of multiple diabetes-related complications." Diabetic Medicine 17(2): 146-151.
    連結:
  73. Morgan, S. L. and J. J. Todd (2008). "A Diagnostic Routine for the Detection of Consequential Heterogeneity of Causal Effects." Sociological Methodology, Vol 38 38: 231-281.
    連結:
  74. Nahra, T. A., K. L. Reiter, R. A. Hirth, J. E. Shermer and J. R. C. Wheeler (2006). "Cost-effectiveness of hospital pay-for-performance incentives." Medical Care Research and Review 63(1): 49s-72s.
    連結:
  75. National Center for Health Statistics (2010). Health, United States, 2009: With Special Feature on Medical Technology.
    連結:
  76. Nicolucci, A., S. Greenfield and S. Mattke (2006). "Selecting indicators for the quality of diabetes care at the health systems level in OECD countries." International Journal for Quality in Health Care 18: 26-30.
    連結:
  77. Oluwatowoju, I., E. Abu, S. H. Wild and C. D. Byrne (2010). "Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: a regional 2-year audit of diabetes care in the UK." Diabetic Medicine 27(3): 354-359.
    連結:
  78. Oluwatowoju, I., E. Abu, S. H. Wild and C. D. Byrne (2010). "Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: a regional 2-year audit of diabetes care in the UK." Diabet Med 27(3): 354-359.
    連結:
  79. Panagiotakos, D. B., C. Pitsavos, C. Chrysohoou and C. Stefanadis (2005). "The epidemiology of Type 2 diabetes mellitus in Greek adults: the ATTICA study." Diabetic Medicine 22(11): 1581-1588.
    連結:
  80. Petersen, L. A., L. D. Woodard, T. Urech, C. Daw and S. Sookanan (2006). "Does pay-for-performance improve the quality of health care?" Annals of Internal Medicine 145(4): 265-272.
    連結:
  81. Petersen, M. and American Diabetes Association (2003). "Economic costs of diabetes in the US in 2002." Diabetes Care 26(3): 917-932.
    連結:
  82. Pham, H. H., D. Schrag, A. S. O'Malley, B. N. Wu and P. B. Bach (2007). "Care patterns in Medicare and their implications for pay for performance." New England Journal of Medicine 356(11): 1130-1139.
    連結:
  83. Phillips, P., D. Wilson, J. Beilby, A. Taylor, E. Rosenfeld, W. Hill and J. Parsons (1998). "Diabetes complications and risk factors in an Australian population. How well are they managed?" International Journal of Epidemiology 27(5): 853-859.
    連結:
  84. Ritz, E., I. Rychlik, F. Locatelli and S. Halimi (1999). "End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions." American Journal of Kidney Diseases 34(5): 795-808.
    連結:
  85. Rosenbaum, P. R. (2002). Observational studies. New York, Springer.
    連結:
  86. Rosenbaum, P. R. and D. B. Rubin (1983). "The Central Role of the Propensity Score in Observational Studies for Causal Effects." Biometrika 70(1): 41-55.
    連結:
  87. Rosenbaum, P. R. and D. B. Rubin (1984). "Reducing Bias in Observational Studies Using Subclassification on the Propensity Score." Journal of the American Statistical Association 79(387): 516-524.
    連結:
  88. Rosenthal, M. B., R. G. Frank, Z. H. Li and A. M. Epstein (2005). "Early experience with pay-for-performance - From concept to practice." Jama-Journal of the American Medical Association 294(14): 1788-1793.
    連結:
  89. Rubin, D. B. (2001). "Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation." Health Services & Outcomes Research Methodology 2: 169-188.
    連結:
  90. Rubin, D. B. (2004). "On principles for modeling propensity scores in medical research." Pharmacoepidemiol Drug Saf 13(12): 855-857.
    連結:
  91. Rubin, D. B. (2004). "On principles for modeling propensity scores in medical research." Pharmacoepidemiology and Drug Safety 13(12): 855-857.
    連結:
  92. Schaars, C. F., P. Denig, W. N. Kasje, R. E. Stewart, B. H. R. Wolffenbuttel and F. M. Haaijer-Ruskamp (2004). "Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care." Diabetes Care 27(1): 123-128.
    連結:
  93. Selby, J. V., A. J. Karter, L. M. Ackerson, A. Ferrara and J. Liu (2001). "Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes." Diabetes Care 24(9): 1547-1555.
    連結:
  94. Shah, B. R., A. Laupacis, J. E. Hux and P. C. Austin (2005). "Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review." Journal of Clinical Epidemiology 58(6): 550-559.
    連結:
  95. Sloan, F. A., D. Belsky, D. Ruiz and P. Lee (2008). "Changes in Incidence of Diabetes Mellitus-Related Eye Disease Among US Elderly Persons, 1994-2005." Archives of Ophthalmology 126(11): 1548-1553.
    連結:
  96. Sloan, F. A., D. S. Grossman and P. P. Lee (2009). "Effects of Receipt of of Guideline-Recommended Care on Onset of Diabetic Retinopathy and Its Progression." Ophthalmology 116(8): 1515-1521.
    連結:
  97. Solli, O., K. Stavem and I. S. Kristiansen (2010). "Health-related quality of life in diabetes: The associations of complications with EQ-5D scores." Health and Quality of Life Outcomes 8(18): 1-8.
    連結:
  98. The Diabetes Control and Complications Trial Research Group (1993). "The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes-Mellitus." New England Journal of Medicine 329(14): 977-986.
    連結:
  99. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005). "Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes." New England Journal of Medicine 353(25): 2643-2653.
    連結:
  100. Titchener, A. G., A. Fakis, A. A. Tambe, C. Smith, R. B. Hubbard and D. I. Clark (2013). "Risk factors in lateral epicondylitis (tennis elbow): a case-control study." J Hand Surg Eur Vol 38(2): 159-164.
    連結:
  101. Tseng, C. H., C. P. Tseng, C. K. Chong, T. P. Huang, Y. M. Song, C. W. Chou, S. M. Lai, T. Y. Tai and J. C. Cheng (2006). "Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort." Diabetologia 49(8): 1755-1760.
    連結:
  102. Turner, R. C. and R. R. Holman (1995). "Lessons from Uk Prospective Diabetes Study." Diabetes Research and Clinical Practice 28: S151-S157.
    連結:
  103. UK Prospective Diabet Study Group (1998). "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)." Lancet 352(9131): 837-853.
    連結:
  104. UK Prospective Diabetes Study Group (1998). "Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38." British Medical Journal 317(7160): 703-713.
    連結:
  105. UK Prospective Diabetes Study Group (2000). "Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study." British Medical Journal 321(7258): 405-412.
    連結:
  106. Vaghela, P., M. Ashworth, P. Schofield and M. C. Gulliford (2009). "Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008." Diabetes Care 32(3): 427-429.
    連結:
  107. Violato, M., A. Gray, I. Papanicolas and M. Ouellet (2012). "Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis." PLoS One 7(7): e41308.
    連結:
  108. Wan, Q., M. F. Harris, U. W. Jayasinghe, J. Flack, A. Georgiou, D. L. Penn and J. R. Burns (2006). "Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice." Quality & Safety in Health Care 15(2): 131-135.
    連結:
  109. Wang, W. B., C. W. Fu, C. Y. Pan, W. Q. Chen, S. Y. Zhan, R. S. Luan, A. Tan, Z. L. Liu and B. Xu (2009). "How Do Type 2 Diabetes Mellitus-Related Chronic Complications Impact Direct Medical Cost in Four Major Cities of Urban China?" Value in Health 12(6): 923-929.
    連結:
  110. Weitzen, S., K. L. Lapane, A. Y. Toledano, A. L. Hume and V. Mor (2004). "Principles for modeling propensity scores in medical research: a systematic literature review." Pharmacoepidemiology and Drug Safety 13(12): 841-853.
    連結:
  111. Wild, S., G. Roglic, A. Green, R. Sicree and H. King (2004). "Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030." Diabetes Care 27(5): 1047-1053.
    連結:
  112. Winship, C. and M. Sobel (2004). Causal inference in sociological studies. Thousand Oasks, CA, Sage.
    連結:
  113. Xu JQ, Kochanek KD, Murphy SL and T.-V. B. (2010). Deaths: Final data for 2007. National vital statistics reports., National Center for Health Statistics.
    連結:
  114. Yang, W. C., S. J. Hwang, S. S. Chiang, H. F. Chen and S. T. Tsai (2001). "The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan." Diabetes Research and Clinical Practice 54: S47-S54.
    連結:
  115. Zhao, Y., W. Ye, K. S. Boye, J. H. Holcombe, J. A. Hall and R. Swindle (2010). "Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy." J Diabetes Complications 24(1): 9-19.
    連結:
  116. 王馨羚 (2008). 「全民健康保險糖尿病醫療給付改善方案」對糖尿病患代謝指標及營養素攝取之影響. 碩士, 臺北醫學大學.
    連結:
  117. 朱桂美 (2008). 糖尿病醫療給付改善方案顯著改善基層診所糖尿病患者糖化血色素. 碩士, 亞洲大學.
    連結:
  118. 行政院衛生署國健康局 (2009). 2008-2009國民健康局年報. 台中市.
    連結:
  119. 余鴻彰 (2010). 論質計酬對糖尿病患低血糖而急診就醫之影響. 碩士, 亞洲大學.
    連結:
  120. 吳慧俞 (2008). 醫療服務改善方案能否避免糖尿病相關之住院. 碩士, 長榮大學.
    連結:
  121. 宋銘展 (2008). 全民健康保險糖尿病醫療給付改善方案五年影響評估. 碩士, 臺灣大學.
    連結:
  122. 李待弟 (2007). 全民健康保險糖尿病醫療給付改善方案初步影響評估. 碩士, 臺灣大學.
    連結:
  123. 冼裕程 (2011). 糖尿病論質計酬對醫療利用與照護成效之影響. 碩士, 長榮大學.
    連結:
  124. 周怡伶 (2008). 糖尿病病患健康狀況差異與糖尿病醫療給付改善方案初步成效之分析. 碩士, 臺灣大學.
    連結:
  125. 林文德, 謝其政, 邱尚志, 吳慧俞 and 黃一展 (2010). "以傾向分數配對法評估糖尿病論質計酬方案之成效." 臺灣公共衛生雜誌 29(1): 54-63.
    連結:
  126. 林佳樺 (2006). 加入論質計酬之糖尿病病患其遵醫性與照護結果之相關性. 碩士, 中國醫藥大學.
    連結:
  127. 林弦音 (2006). 縱貫性探討糖尿病及其相關慢性併發症之盛行率和長期醫療資源利用. 碩士, 高雄醫學大學.
    連結:
  128. 邱淑媞, 李玉春, 周碧瑟, 林瑞祥, 林宏達, 陳良娟, 陳國群, 游能俊, 葉彥伯, 劉媛媛, 蔡世澤, 賴美淑, 盧介祥, 宜蘭縣政府衛生局 and 行政院衛生署國民健康局 (2002). 糖尿病共同照護工作指引手冊.
    連結:
  129. 柳奕朱 (2011). 論質計酬對糖尿病病患視網膜病變診斷之影響及相關因素之探討. 碩士, 中國醫藥大學.
    連結:
  130. 張順全, 賴美淑 and 徐豈庸 (2005). "台灣地理區域社經差異與糖尿病患罹病、死亡的關聯性探討." 醫護科技學刊 7(2): 140-148.
    連結:
  131. 張祺玩 (2010). 糖尿病醫療給付改善方案之醫療盡責度與照護結果之相關性. 碩士, 長榮大學.
    連結:
  132. 許祐堡 (2006). 參與全民健康保險糖尿病醫療給付改善方案之病患其醫療資源利用情形之探討—以某區域醫院為例. 碩士, 元智大學.
    連結:
  133. 郭建志 (2008). 全民健康保險糖尿病醫療給付改善方案對糖尿病病人醫療資源利用的影響評估. 碩士, 高雄醫學大學.
    連結:
  134. 陳祐安 (2009). 糖尿病醫療給付改善方案對糖尿病足患者醫療利用之影響. 碩士, 臺灣大學.
    連結:
  135. 黃三桂, 王悅萍 and 錢慶文 (2002). "疾病管理對糖尿病患醫療資源耗用之影響." 台灣醫務管理雜誌 3(2): 35-47.
    連結:
  136. 黃齡慧 (2011). 全民健康保險糖尿病醫療給付改善方案之果效研究與糖尿病患生活品質評估. 碩士, 高雄醫學大學.
    連結:
  137. 葉素吟 (2010). 糖尿病醫療給付改善方案長期介入成效與影響因子之探討. 碩士, 亞洲大學.
    連結:
  138. 蔡旻君 (2010). 醫療給付改善方案是否影響醫師照護行為-以糖尿病為例. 碩士, 臺灣大學.
    連結:
  139. 鄭弘美, 溫敏杰, 周慧玲, 李婉瑜 and 蔡晨瑩 (2005). "利用健保資料探討糖尿病住院醫療照護." 內科學誌 16(3): 121-128.
    連結:
  140. 鍾文誠 (2012). 糖尿病病患參與論質計酬方案對執行冠狀動脈繞道手術預後之影響. 碩士, 國立陽明大學.
    連結:
  141. 魏榮男, 宋鴻樟, 林瑞雄, 李中一, 莊明雄, 王博仁, 周劍文, 童瑞年 and 莊立民 (2002). "各級醫院糖尿病慢性合併症住院現況探討." 臺灣公共衛生雜誌 21(2): 115-122.
    連結:
  142. 魏榮男, 莊立民, 林瑞雄, 趙嘉玲 and 宋鴻樟 (2002). "1996~2000年台灣地區糖尿病盛行率與住院率." 臺灣公共衛生雜誌 21(3): 73-180.
    連結:
  143. Agency for Healthcare Research and Quality, A. (2010). "Diabetes Care Quality Improvement: Resource Guide." Appendix G: Index of Diabetes Quality Improvement Initiatives Retrieved 12/29, 2010, from http://www.ahrq.gov/qual/diabqual/diabqguideapg.htm.
  144. Chan, J. C. N., V. Malik, W. P. Jia, T. Kadowaki, C. S. Yajnik, K. H. Yoon and F. B. Hu (2009). "Diabetes in Asia Epidemiology, Risk Factors, and Pathophysiology." Jama-Journal of the American Medical Association 301(20): 2129-2140.
  145. Chen, J. Y., H. J. Tian, D. T. Juarez, K. A. Hodges, J. C. Brand, R. S. Chung and A. P. Legorreta (2010). "The Effect of a PPO Pay-for-Performance Program on Patients With Diabetes." American Journal of Managed Care 16(1): E11-E19.
  146. Chew, E. Y., W. T. Ambrosius, M. D. Davis, R. P. Danis, S. Gangaputra, C. M. Greven, L. Hubbard, B. A. Esser, J. F. Lovato, L. H. Perdue, D. C. Goff, W. C. Cushman, H. N. Ginsberg, M. B. Elam, S. Genuth, H. C. Gerstein, U. Schubart, L. J. Fine, A. S. Grp and A. E. S. Grp (2010). "Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes." New England Journal of Medicine 363(3): 233-244.
  147. Diabetes Federation of Irland. (1989, 2009/05/29). "Diabetes care and research in Europe: The St Vincent Declaration." Retrieved 12, 2010, from http://www.diabetes.ie/website/content/diabetes_in_ireland/st_vincent_declaration.aspx.
  148. Faries;, D. E., A. C. Leon;, J. M. Haro; and R. L. Obenchain; (2010). Analysis of Observational Health Care Data Using SAS, SAS Institute.
  149. Halanych, J. H., M. M. Safford, S. D. Person, J. M. Shikany, R. M. Centor and J. J. Allison (2007). "The burden of comorbid medical conditions and diabetes performance measures: Too much testing, too little, or just right?" Circulation 115(8): E252-E252.
  150. Harrington, D. (2005). Linear Rank Tests in Survival Analysis. Encyclopedia of Biostatistics, John Wiley & Sons, Ltd.
  151. Hwang, S., W. Yang, S. Hwang and H. Lin (2005). "Data analysis from the application for uremic major illness card from 2001 to 2003. [Abstract]." ACTA Nephrologica 19: 376.
  152. Krans, H., M. Porta, H. Keen and J. K. Staehr (1995). Diabetes care and research in Europe: the St Vincent Declaration Action Programme; implementation document. Copenhagen, World Health Organisation, Regional Office for Europe.
  153. Lee, T. T., S. H. Cheng, C. C. Chen and M. S. Lai (2010). "A Pay-for-Performance Program for Diabetes Care in Taiwan: A Preliminary Assessment." American Journal of Managed Care 16(1): 65-69.
  154. Mangione, C. M., R. B. Gerzoff, D. F. Williamson, W. N. Steers, E. A. Kerr, A. F. Brown, B. E. Waitzfelder, D. G. Marrero, R. A. Dudley, C. Kim, W. Herman, T. J. Thompson, M. M. Safford, J. V. Selby and T. S. Grp (2006). "The association between quality of care and the intensity of diabetes disease management programs." Annals of Internal Medicine 145(2): 107-116.
  155. Rosenbaum, P. R. (2005). Sensitivity Analysis in Observational Studies. Encyclopedia of Statistics in Behavioral Science, John Wiley & Sons, Ltd.
  156. Rosenzweig, J. L., K. Weinger, L. Poirier-Solomon and M. Rushton (2002). "Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus." American Journal of Managed Care 8(11): 950-958.
  157. Sidorov, J., R. Shull, J. Tomcavage, S. Girolami, N. Lawton and R. Harris (2002). "Does diabetes disease management save money and improve outcomes?" Diabetes Care 25(4): 684-689.
  158. Vinik, A. I., T. S. Park, K. B. Stansberry and G. L. Pittenger (2000). "Diabetic neuropathies." Diabetologia 43(8): 957-973.
  159. Young, B. A., E. Lin, M. Von Korff, G. Simon, P. Ciechanowski, E. J. Ludman, S. Everson-Stewart, L. Kinder, M. Oliver, E. J. Boyko and W. J. Katon (2008). "Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization." American Journal of Managed Care 14(1): 15-24.
  160. 中央健康保險局 (2008) "糖尿病專業醫療服務品質報告."
  161. 行政院衛生署中央健康保險局 (2012). 100年度全民健康保險醫療統計年報. 台北市.
  162. 國家衛生研究院. (2013). "全民健康保險學術資料庫." Retrieved July 1, 2013, from http://nhird.nhri.org.tw/date_cohort.htm.
  163. 許惠恒 (2003). 糖尿病醫療給付改善方案在某醫學中心實施成效探討. 碩士, 國立臺灣大學.
  164. 陳珮青 (2012). 區域醫療資源及論質計酬對不同社經位置糖尿病患健康照護品質與健康結果的影響-多層次分析. 博士, 國立陽明大學.
  165. 衛生福利部統計處 (2012). 101年度死因統計 台北市.
被引用次数
  1. 蔡茜如(2014)。糖尿病醫療給付改善方案、照護過程品質與可避免住院之相關性探討。國立臺灣大學健康政策與管理研究所學位論文。2014。1-98。